Join
Live feed
·
INSIDERFilingvia Quantisnow
Verona Pharma plc logo

President and CEO Zaccardelli David converted options into 229,512 units of Ordinary Shares and sold $811,433 worth of Ordinary Shares (90,360 units at $8.98), increasing direct ownership by 0.98% to 14,377,176 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VRNA· Verona Pharma plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRNA (Verona Pharma plc) and more on Quantisnow.

President and CEO Zaccardelli David converted options into 229,512 units of Ordinary Shares and sold $811,433 worth of Ordinary Shares (90,360 units at $8.98), increasing direct ownership by 0.98% to 14,377,176 units (SEC Form 4) | Quantisnow